Our results demonstrate for the first time that close spatial proximity of CD163+ TAMs to cancer cells and the average number of adjacent or communicating CD163+ TAMs are independent predictors of unfavorable prognosis in breast cancer. Here, CD163 is linked to breast carcinoma.